Clinical Trial Update: Neoadjuvant Folfirinox Followed by Capecitabine and Limited Field Radiation for Localized Pancreatic Head Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant FOLFIRINOX followed by capecitabine and limited-field radiation for localized pancreatic head adenocarcinoma; the study was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Capecitabine (capecitabine)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Adenocarcinoma of Head of Pancreas | Phase 2 | Status: TERMINATED | Results posted: 2016-01-15